Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats

Hypertension

Volumn 30, Issue 6, 1997, Pages 1448-1454

  Nakano, Nobuaki ^a   Moriguchi, Atsushi ^a   Morishita, Ryuichi ^a   Kida, Iwao ^a   Tomita, Naruya ^a   Matsumoto, Kunio ^a   Nakamura, Toshikazu ^a   Higaki, Jitsuo ^a   Ogihara, Toshio ^a,b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Arteriosclerosis; Cardiovascular hepatocyte growth factor system; Endothelial cell; Remodeling

Indexed keywords

ANGIOTENSIN; SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART LEFT VENTRICLE SIZE; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

EID: 0030659825     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.6.1448     Document Type: Article

References (37)

1. Tare M, Parkington HC, Coleman HA, Neild TO, Dusting GJ. Hyperpolarization and relaxation of atrial smooth muscle caused by nitric oxide derived from the endothelium. Nature. 1990;346:69-71.
2. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β: possible existence of 'vascular natriuretic peptide system.' J Clin Invest. 1992;90:1145-1149.
3. Itoh H, Pratt RE, Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest. 1990;86: 1690-1697.
4. Cohn JM, Finkelstein SM. Abnormalities of vascular compliance in hypertension, aging and heart failure. J Hypertens. 1992;10(suppl 6):561-564.
5. Lockette W, Otsuka Y, Carretero OA. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension. 1986; 8(suppl II):II-61-II-66.
6. Diedrich D, Yang Z, Buhler FR, Luscher TF. Impaired endothelium-dependent relaxation in hypertensive resistance arteries involves cyclooxygenase pathway. Am J Physiol. 1988;258: H445-H451.
7. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
8. Dzau VJ, Gibbons GH. Endothelium and growth factors in vascular remodeling of hypertension. Hypertension. 1991;18(suppl III):III-115-III-121.
9. Dzau VJ. The role of mechanical and humoral factors in growth regulation of vascular smooth muscle cells and cardiac myocytes. Curr Opin Nephrol Hypertens. 1993;2:27-32.
10. Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Nakano H, Matsumoto K, Nakamura T, Ogihara T. Hepatocyte growth factor (HGF) is a novel member of endothelium-specific growth factors: additive stimulatory effect of HGF with basic fibroblast growth factor, but not vascular endothelial growth factor. J Hypertens. 1996;14:1067-1072.
11. Matsumoto K, Nakamura T. Role of HGF as a pleiotropic factor in organ regeneration. In: Goldberg ID, Rosen EM, eds. Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and C-Met Receptor. Basel, Switzerland: Birkhauser Verlag; 1993:225-249.
12. Nakamura T. Structure and function of hepatocyte growth factor. Prog Growth Factor Res. 1991;3:67-86.
13. Boros P, Miller CM. Hepatocyte growth factor: a multifunctional cytokine. Lancet. 1995;345:293-295.
14. Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Matsumoto K, Nakamura T. Expression of local hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun. 1995;215:483-488.
15. Nakamura Y, Morishita R, Higaki J, Kida I, Hayashi S, Aoki M, Yo Y, Moriguchi A, Matsumoto K, Nakamura T, Ogihara T. Differential regulation of local hepatocyte growth factor, endothelium-specific growth factor, production in vascular cells. J Hypertens. 1996;14:S70. Abstract.
16. Morishita R, Higaki J, Miyazaki M, Ogihara T. Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension. 1992;19(suppl II):II-62-II-67.
17. Wang DH, Prewitt RL. Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension. 1990; 15:68-77.
18. Okamura T. Miyazaki M, Inagami T. Toda N. Vascular renin angiotensin system in two-kidney, one clip hypertensive rats. Hypertension. 1986;8:560-565.
19. Sarzani R, Brecher P, Chobanian AV. Growth factor expression in aorta of normotensive and hypertensive rats. J Clin Invest. 1989;83: 1404-1498.
20. Nakamura Y, Morishita R, Nakamura S, Aoki M, Moriguchi A, Matsumoto K, Nakamura T, Higaki J, Ogihara T. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension. 1996;28:409-413.
21. Yamada A, Matsumoto K, Iwanari H, Sekiguchi K, Kawata S, Matsuzawa Y, Nakamura T. Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues. Biomed Res. 1995;16:105-114.
22. Shimamoto K, Ishida H, Nakahashi Y, Nishitani T, Hosoda S, Yokoyama T, Tanaka S, Iimura O. A very sensitive direct radioimmunoassay system for plasma angiotensin II and its clinical application in various hypertensive diseases. Jpn Circ J. 1984;48:228-235.
23. Matsumoto K, Tashiro K, Tajima H, Okazaki H, Nakamura T. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-β and glucocorticoids. J Biol Chem. 1992;267:24917-24920.
24. Okajima A, Miyazawa K, Kitamura N. Characterization of the promoter region of the rat hepatocyte-growth-factor/scatter-factor gene. Eur J Biochem. 1993;213:113-119.
25. Gohda E, Matsunaga T, Kataoka H, Yamamoto I. TGF-β is a potent inhibitor of hepatocyte growth factor secretion by human fibroblasts. Cell Biol Int. 1992;16:917-926.
26. Amann K, Gharehbaghi H, Stephen S, Mall G. Hypertrophy and hyperplasia of smooth muscle cells of small intramyocardial arteries in spontaneously hypertensive rats. Hypertension. 1995;25:124-131.
27. Motz W, Strauer BE. Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation. J Cardiovasc Pharmacol. 1994;24:834-838.
28. Tomanek RJ, Torry RJ. Growth of the coronary vasculature in hypertrophy: mechanisms and model dependence. Cell Mol Biol Res. 1994;40:129-136.
29. Secchi J, Lecaque D, Dunn FW, Jouquey S, Auberval UD, Benzoni F, Sirugue O, Hamon G. Effects of subchronic treatment with trandolapril and enalapril on cardiovascular morphologic alterations in the aged spontaneously hypertensive rats with heart failure. J Cardiovasc Pharmacol. 1994;23:530-537.
30. Bussolino F, DiRenzo MF, Ziche M, Bocchietto E, Olivero M, Naidini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol. 1992;119: 629-641.
31. Silvagno F, Follenzi A, Arese M, Prat M, Giraudo E, Gaudino G, Camussi G, Comoglio PM, Bussolino F. In vivo activation of met tyrosine kinase by heterodimeric hepatocyte growth factor molecule promotes angiogenesis. Arterioscler Thromb Vasc Biol. 1995;15:1857-1865.
32. Araki S, Shimada Y, Kaji K, Hayashi H. Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun. 1990;168:1194-1200.
33. Morishita R, Higaki J, Nakamura Y, Kida I, Hayashi S, Aoki M, Moriguchi A, Matsumoto K, Nakamura T, Ogihara T. Anti-apoptotic action of hepatocyte growth factor (HGF) on endothelial cells: role of HGF in cardiovascular disease. J Hypertens. 1996; 14:5150. Abstract.
34. Morishita R, Nakamura S, Nakamura Y, Aoki M, Moriguchi A, Kida I, Yo Y, Matsumoto K, Nakamura T, Higaki J, Ogihara T. Potential role of endothelium-specific growth factor, hepatocyte growth factor, in endothelial damage in diabetes mellitus. Diabetes. 1997;46:138-142.
35. Takeda K, Fujita H, Nakamura K, Uchida A, Tanaka M, Itho H, Nakata T, Sasaki S, Nakagawa M. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats. Blood Press. 1994;5:94-98.
36. Oddie CJ, Dilley RJ, Kanekkakis P, Bobik A. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity. J Hypertens. 1993;11:717-724.
37. Lee MA, Paul M, Bohm M, Ganten D. Effects of angiotensin converting enzyme inhibitors on tissue renin-angiotensin systems. Am J Cardiol. 1992;70:12C-19C.